224 related articles for article (PubMed ID: 29930300)
1. The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALL.
Kampen KR; Sulima SO; Verbelen B; Girardi T; Vereecke S; Rinaldi G; Verbeeck J; Op de Beeck J; Uyttebroeck A; Meijerink JPP; Moorman AV; Harrison CJ; Spincemaille P; Cools J; Cassiman D; Fendt SM; Vermeersch P; De Keersmaecker K
Leukemia; 2019 Feb; 33(2):319-332. PubMed ID: 29930300
[TBL] [Abstract][Full Text] [Related]
2. The T-cell leukemia-associated ribosomal RPL10 R98S mutation enhances JAK-STAT signaling.
Girardi T; Vereecke S; Sulima SO; Khan Y; Fancello L; Briggs JW; Schwab C; de Beeck JO; Verbeeck J; Royaert J; Geerdens E; Vicente C; Bornschein S; Harrison CJ; Meijerink JP; Cools J; Dinman JD; Kampen KR; De Keersmaecker K
Leukemia; 2018 Mar; 32(3):809-819. PubMed ID: 28744013
[TBL] [Abstract][Full Text] [Related]
3. Ribosomal Lesions Promote Oncogenic Mutagenesis.
Sulima SO; Kampen KR; Vereecke S; Pepe D; Fancello L; Verbeeck J; Dinman JD; De Keersmaecker K
Cancer Res; 2019 Jan; 79(2):320-327. PubMed ID: 30482776
[TBL] [Abstract][Full Text] [Related]
4. The T-cell leukemia related rpl10-R98S mutant traps the 60S export adapter Nmd3 in the ribosomal P site in yeast.
Patchett S; Musalgaonkar S; Malyutin AG; Johnson AW
PLoS Genet; 2017 Jul; 13(7):e1006894. PubMed ID: 28715419
[TBL] [Abstract][Full Text] [Related]
5. Translatome analysis reveals altered serine and glycine metabolism in T-cell acute lymphoblastic leukemia cells.
Kampen KR; Fancello L; Girardi T; Rinaldi G; Planque M; Sulima SO; Loayza-Puch F; Verbelen B; Vereecke S; Verbeeck J; Op de Beeck J; Royaert J; Vermeersch P; Cassiman D; Cools J; Agami R; Fiers M; Fendt SM; De Keersmaecker K
Nat Commun; 2019 Jun; 10(1):2542. PubMed ID: 31186416
[TBL] [Abstract][Full Text] [Related]
6. ABT-199 mediated inhibition of BCL-2 as a novel therapeutic strategy in T-cell acute lymphoblastic leukemia.
Peirs S; Matthijssens F; Goossens S; Van de Walle I; Ruggero K; de Bock CE; Degryse S; Canté-Barrett K; Briot D; Clappier E; Lammens T; De Moerloose B; Benoit Y; Poppe B; Meijerink JP; Cools J; Soulier J; Rabbitts TH; Taghon T; Speleman F; Van Vlierberghe P
Blood; 2014 Dec; 124(25):3738-47. PubMed ID: 25301704
[TBL] [Abstract][Full Text] [Related]
7. Bypass of the pre-60S ribosomal quality control as a pathway to oncogenesis.
Sulima SO; Patchett S; Advani VM; De Keersmaecker K; Johnson AW; Dinman JD
Proc Natl Acad Sci U S A; 2014 Apr; 111(15):5640-5. PubMed ID: 24706786
[TBL] [Abstract][Full Text] [Related]
8. Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia.
De Keersmaecker K; Atak ZK; Li N; Vicente C; Patchett S; Girardi T; Gianfelici V; Geerdens E; Clappier E; Porcu M; Lahortiga I; Lucà R; Yan J; Hulselmans G; Vranckx H; Vandepoel R; Sweron B; Jacobs K; Mentens N; Wlodarska I; Cauwelier B; Cloos J; Soulier J; Uyttebroeck A; Bagni C; Hassan BA; Vandenberghe P; Johnson AW; Aerts S; Cools J
Nat Genet; 2013 Feb; 45(2):186-90. PubMed ID: 23263491
[TBL] [Abstract][Full Text] [Related]
9. Exploitation of the ribosomal protein L10 R98S mutation to enhance recombinant protein production in mammalian cells.
Verbelen B; Girardi T; Sulima SO; Vereecke S; Verstraete P; Verbeeck J; Royaert J; Cinque S; Montanaro L; Penzo M; Imbrechts M; Geukens N; Geuens T; Dierckx K; Pepe D; Kampen K; De Keersmaecker K
Eng Life Sci; 2022 Feb; 22(2):100-114. PubMed ID: 35140557
[TBL] [Abstract][Full Text] [Related]
10. Maturation stage of T-cell acute lymphoblastic leukemia determines BCL-2 versus BCL-XL dependence and sensitivity to ABT-199.
Chonghaile TN; Roderick JE; Glenfield C; Ryan J; Sallan SE; Silverman LB; Loh ML; Hunger SP; Wood B; DeAngelo DJ; Stone R; Harris M; Gutierrez A; Kelliher MA; Letai A
Cancer Discov; 2014 Sep; 4(9):1074-87. PubMed ID: 24994123
[TBL] [Abstract][Full Text] [Related]
11. T-ALL: ALL a matter of Translation?
Girardi T; De Keersmaecker K
Haematologica; 2015 Mar; 100(3):293-5. PubMed ID: 25740104
[No Abstract] [Full Text] [Related]
12. Targeting BET proteins improves the therapeutic efficacy of BCL-2 inhibition in T-cell acute lymphoblastic leukemia.
Peirs S; Frismantas V; Matthijssens F; Van Loocke W; Pieters T; Vandamme N; Lintermans B; Dobay MP; Berx G; Poppe B; Goossens S; Bornhauser BC; Bourquin JP; Van Vlierberghe P
Leukemia; 2017 Oct; 31(10):2037-2047. PubMed ID: 28074072
[TBL] [Abstract][Full Text] [Related]
13. Mutational analysis of ribosomal proteins in a cohort of pediatric patients with T-cell acute lymphoblastic leukemia reveals Q123R, a novel mutation in RPL10.
Bacci L; Indio V; Rambaldelli G; Bugarin C; Magliocchetti F; Del Rio A; Pollutri D; Melchionda F; Pession A; Lanciotti M; Dufour C; Gaipa G; Montanaro L; Penzo M
Front Genet; 2022; 13():1058468. PubMed ID: 36482893
[TBL] [Abstract][Full Text] [Related]
14. Eukaryotic rpL10 drives ribosomal rotation.
Sulima SO; Gülay SP; Anjos M; Patchett S; Meskauskas A; Johnson AW; Dinman JD
Nucleic Acids Res; 2014 Feb; 42(3):2049-63. PubMed ID: 24214990
[TBL] [Abstract][Full Text] [Related]
15. Plant L10 ribosomal proteins have different roles during development and translation under ultraviolet-B stress.
Falcone Ferreyra ML; Pezza A; Biarc J; Burlingame AL; Casati P
Plant Physiol; 2010 Aug; 153(4):1878-94. PubMed ID: 20516338
[TBL] [Abstract][Full Text] [Related]
16. A Novel Mutation in RPL10 (Ribosomal Protein L10) Causes X-Linked Intellectual Disability, Cerebellar Hypoplasia, and Spondylo-Epiphyseal Dysplasia.
Zanni G; Kalscheuer VM; Friedrich A; Barresi S; Alfieri P; Di Capua M; Haas SA; Piccini G; Karl T; Klauck SM; Bellacchio E; Emma F; Cappa M; Bertini E; Breitenbach-Koller L
Hum Mutat; 2015 Dec; 36(12):1155-8. PubMed ID: 26290468
[TBL] [Abstract][Full Text] [Related]
17. An investigation of ribosomal protein L10 gene in autism spectrum disorders.
Gong X; Delorme R; Fauchereau F; Durand CM; Chaste P; Betancur C; Goubran-Botros H; Nygren G; Anckarsäter H; Rastam M; Gillberg IC; Kopp S; Mouren-Simeoni MC; Gillberg C; Leboyer M; Bourgeron T
BMC Med Genet; 2009 Jan; 10():7. PubMed ID: 19166581
[TBL] [Abstract][Full Text] [Related]
18. Correction: The ribosomal RPL10 R98S mutation drives IRES-dependent BCL-2 translation in T-ALL.
Kampen KR; Sulima SO; Verbelen B; Girardi T; Vereecke S; Fancello L; Rinaldi G; Verbeeck J; Op de Beeck J; Uyttebroeck A; Meijerink JPP; Moorman AV; Harrison CJ; Spincemaille P; Cools J; Cassiman D; Fendt SM; Vermeersch P; De Keersmaecker K
Leukemia; 2019 Apr; 33(4):1055-1062. PubMed ID: 30850735
[TBL] [Abstract][Full Text] [Related]
19. Bcl-2 Is a Therapeutic Target for Hypodiploid B-Lineage Acute Lymphoblastic Leukemia.
Diaz-Flores E; Comeaux EQ; Kim KL; Melnik E; Beckman K; Davis KL; Wu K; Akutagawa J; Bridges O; Marino R; Wohlfeil M; Braun BS; Mullighan CG; Loh ML
Cancer Res; 2019 May; 79(9):2339-2351. PubMed ID: 30862722
[TBL] [Abstract][Full Text] [Related]
20. Role of ribosomal protein mutations in tumor development (Review).
Goudarzi KM; Lindström MS
Int J Oncol; 2016 Apr; 48(4):1313-24. PubMed ID: 26892688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
